Clinical Trial Update: Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adding acamprosate to escitalopram and behavioral therapy for comorbid major depressive disorder and alcohol use disorders; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Abuse
• Alcohol Dependence
• Major Depressive Disorder

Drugs mentioned

• Campral (acamprosate)
• Escitalopram (escitalopram)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder, Alcohol Abuse | Phase 4 | Status: COMPLETED | Results posted: 2012-07-09